验证一种评估剖宫产产科人群估计失血量的新方法
本研究在242例剖宫产产妇中比较Triton定量系统与术者主观估计失血量,Triton平均失血量显著低于主观估计(415.3±260.6 vs 799.6±215.6 mL,P<.01),且Triton与delta血红蛋白相关性最佳,能预测delta血红蛋白≥2 g/dL,而主观估计不能。
要点
- Triton系统测得的平均失血量显著低于术者主观估计(415.3±260.6 vs 799.6±215.6 mL,P<.01)。
- Triton测量与delta血红蛋白相关性最佳,且能预测delta血红蛋白≥2 g/dL(AUC 0.66,95%CI 0.58-0.74;P<.01 vs 主观估计AUC 0.53,95%CI 0.45-0.61;P=.45)。
- 作者认为Triton系统比视觉估计能更好地评估失血量,但需要临床试验评估其获益。
核心结论
- Triton系统比视觉估计能更好地评估失血量。
- 需要临床试验评估其获益。
研究设计与样本
- 在本机构计划行剖宫产的产妇中开展研究,共入组242例患者。
- 术中失血量分别采用对临床团队设盲的Triton系统测量和术者主观估计失血量进行评估。
- 采用Spearman相关分析评估两种方法与术后血红蛋白及delta血红蛋白(术后减术前血红蛋白)的关系。
- 比较delta血红蛋白位于上四分位(病例组)与其他四分位(对照组)产妇的Triton测量值和主观估计失血量,并比较两种方法预测delta血红蛋白位于上四分位的ROC曲线下面积。
主要发现
- Triton设备估计的平均失血量显著低于临床判断估计(415.3±260.6 vs 799.6±215.6 mL,P<.01)。
- Triton估计值与delta血红蛋白相关性最佳。
- 70例患者delta血红蛋白位于上四分位(delta血红蛋白≥2)。
- 病例组与对照组之间Triton失血量测量值有显著差异,而主观估计失血量无差异。
- Triton能预测delta血红蛋白≥2 g/dL(AUC 0.66;95%CI 0.58-0.74;P<.01 vs 主观估计失血量AUC 0.53;95%CI 0.45-0.61;P=.45),而主观估计失血量不能预测。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postpartum hemorrhage is the leading cause of maternal mortality in developing countries and the primary cause of one-quarter of all maternal deaths globally. Inaccuracy in estimating blood loss obscures the diagnosis of postpartum hemorrhage and its management. OBJECTIVE: Our objective was to compare assessment of blood loss using the quantitative Triton system (Gauss Surgical, Inc, Los Altos, CA) with other measures of blood loss in women undergoing cesarean delivery. STUDY DESIGN: Women scheduled for cesarean deliveries at our facility were included. Intraoperative blood loss was measured using the Triton, which was masked to the clinical team, as well as estimated by the surgeon (subjective estimated blood loss). The relation between the 2 methods (Triton and subjective estimated blood loss) and postoperative hemoglobin as well as delta hemoglobin (postoperative minus preoperative hemoglobin) was determined using the Spearman correlation. Triton measurement and subjective estimated blood loss were compared between women with delta hemoglobin in the upper quartile (cases) vs all other quartiles (control). Prediction of delta hemoglobin in the upper quartile also was evaluated for each method, and the area under the receiver operating characteristic curves was compared. RESULTS: The trial enrolled 242 patients. The mean blood loss estimated by the Triton device was significantly lower than that estimated by clinical judgment (415.3±260.6 vs 799.6±215.6 mL, P<.01). The Triton estimate correlated best with delta hemoglobin. Seventy patients had delta hemoglobin in the upper quartile (delta hemoglobin ≥2). There was a significant difference in the Triton blood loss measurement between cases and controls but no difference with subjective estimated blood loss. Triton, but not subjective estimated blood loss, was predictive of delta hemoglobin ≥2 g/dL (Triton: area under the receiver operating characteristic curve, 0.66; 95% confidence interval, 0.58-0.74; P<.01 vs subjective estimated blood loss: area under the receiver operating characteristic curve, 0.53; 95% confidence interval, 0.45-0.61; P=.45). CONCLUSIONS: The Triton system provides a better estimate of blood loss than the visual estimate. Clinical trials to evaluate its benefit are warranted.
引用
- Saoud F, Stone A, Nutter A, et al. Validation of a new method to assess estimated blood loss in the obstetric population undergoing cesarean delivery. Am J Obstet Gynecol. 2019. PMID: 31229429. doi:10.1016/j.ajog.2019.06.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。